Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bayer Lung Drug Should Be Approved at Low Dose, FDA Says
Bayer Lung Drug Should Be Approved at Low Dose, FDA Says
Bayer Lung Drug Should Be Approved at Low Dose, FDA Says
Submitted by
admin
on August 2, 2013 - 10:53am
Source:
Bloomberg
News Tags:
Bayer
FDA
drug approvals
pulmonary hypertension
Riociguat
Headline:
Bayer Lung Drug Should Be Approved at Low Dose, FDA Says
Do Not Allow Advertisers to Use My Personal information